Evidence map›Paper›PMID 26279205›Full record

ArticleAmerican journal of human genetics2015

Haploinsufficiency of the NF-κB1 Subunit p50 in Common Variable Immunodeficiency.

Manfred Fliegauf, Vanessa L Bryant, Natalie Frede, Charlotte Slade, See-Tarn Woon, Klaus Lehnert, Sandra Winzer, Alla Bulashevska, Thomas Scerri, Euphemia Leung and 12 more

Open access · bronzeAbstract readCase ReportsMulticenter Study
In one paragraph

Article in American journal of human genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 137 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
137citing papers in PubMed, 2 pooled it
9.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

137 citing papers in PubMed, 2 syntheses or guidelines pooled it, 240 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Clinical and immunological characterization ofFrontiers in immunology · 2026
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. γδ T Cells and Inborn Errors of Immunity.European journal of immunology · 2025
    Review
  15. Review
  16. Analysis of the Relationship BetweenInternational journal of medical sciences · 2025
    Article
  17. Review
  18. Article
  19. Cytomegalovirus drives Vδ1Nature communications · 2024
    Article
  20. Article

77 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 10 institutions in 7 countries.

Manfred FliegaufCenter for Chronic Immunodeficiency, University Medical Center Freiburg and University of Freiburg, Freiburg 79108, Germany.
Vanessa L BryantDivision of Immunology, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia; Department of Medical Biology, The University of Melbourne, Parkville, VIC 3010, Australia.
Natalie FredeCenter for Chronic Immunodeficiency, University Medical Center Freiburg and University of Freiburg, Freiburg 79108, Germany.
Charlotte SladeDivision of Immunology, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia; Department of Medical Biology, The University of Melbourne, Parkville, VIC 3010, Australia; Department of Clinical Immunology and Allergy, Royal Melbourne Hospital, Parkville, VIC 3050, Australia.
See-Tarn WoonDepartment of Virology and Immunology, Auckland City Hospital, Auckland 1023, New Zealand.
Klaus LehnertSchool of Biological Sciences, University of Auckland, Auckland 1142, New Zealand.
Sandra WinzerCenter for Chronic Immunodeficiency, University Medical Center Freiburg and University of Freiburg, Freiburg 79108, Germany.
Alla BulashevskaCenter for Chronic Immunodeficiency, University Medical Center Freiburg and University of Freiburg, Freiburg 79108, Germany.
Thomas ScerriDivision of Immunology, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia; Department of Medical Biology, The University of Melbourne, Parkville, VIC 3010, Australia.
Euphemia LeungAuckland Cancer Society Research Centre and Molecular Medicine and Pathology Department, University of Auckland, Auckland 1142, New Zealand.
Anthony JordanDepartment of Clinical Immunology, Auckland City Hospital, Auckland 1023, New Zealand.
Baerbel KellerCenter for Chronic Immunodeficiency, University Medical Center Freiburg and University of Freiburg, Freiburg 79108, Germany.
Esther de VriesDepartment of Pediatrics, Jeroen Bosch Hospital, 's-Hertogenbosch 5200 ME, the Netherlands.
Hongzhi CaoBGI-Shenzhen, Shenzhen, 518083, China.
Fang YangBGI-Shenzhen, Shenzhen, 518083, China.
Alejandro A SchäfferNCBI, NIH, Department of Health and Human Services, Bethesda, MD 20894, USA.
Klaus WarnatzCenter for Chronic Immunodeficiency, University Medical Center Freiburg and University of Freiburg, Freiburg 79108, Germany.
Peter BrowettAuckland Cancer Society Research Centre and Molecular Medicine and Pathology Department, University of Auckland, Auckland 1142, New Zealand.
Jo DouglassDivision of Immunology, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia; Department of Clinical Immunology and Allergy, Royal Melbourne Hospital, Parkville, VIC 3050, Australia; Department of Medicine, The University of Melbourne, Parkville, VIC 3010, Australia.
Rohan V AmeratungaDepartment of Virology and Immunology, Auckland City Hospital, Auckland 1023, New Zealand.
Jos W M van der MeerDepartment of Internal Medicine, Radboud University Medical Centre, Nijmegen 6525 HP, the Netherlands.
Bodo GrimbacherCenter for Chronic Immunodeficiency, University Medical Center Freiburg and University of Freiburg, Freiburg 79108, Germany; Institute of Immunity and Transplantation, University College London, London WC1E 6BT, UK. Electronic address: bodo.grimbacher@uniklinik-freiburg.de.
University of Freiburg · DEAuckland City Hospital · NZWalter and Eliza Hall Institute of Medical Research · AUBGI Group (China) · CNUniversity Medical Center Freiburg · DEUniversity of Auckland · NZCancer Society of New Zealand · NZRadboud University Medical Center · NLThe Royal Melbourne Hospital · AUUnited States Department of Health and Human Services · US

Funding

Case Studies In GeneticsZIALM000097 · NLM · NATIONAL LIBRARY OF MEDICINE · PI SCHAFFER, ALEJANDRO A · 2009 to 2019
$4.6M
Intramural NIH HHS
6 · The paper itself

Abstract

Common variable immunodeficiency (CVID), characterized by recurrent infections, is the most prevalent symptomatic antibody deficiency. In ∼90% of CVID-affected individuals, no genetic cause of the disease has been identified. In a Dutch-Australian CVID-affected family, we identified a NFKB1 heterozygous splice-donor-site mutation (c.730+4A>G), causing in-frame skipping of exon 8. NFKB1 encodes the transcription-factor precursor p105, which is processed to p50 (canonical NF-κB pathway). The altered protein bearing an internal deletion (p.Asp191_Lys244delinsGlu; p105ΔEx8) is degraded, but is not processed to p50ΔEx8. Altered NF-κB1 proteins were also undetectable in a German CVID-affected family with a heterozygous in-frame exon 9 skipping mutation (c.835+2T>G) and in a CVID-affected family from New Zealand with a heterozygous frameshift mutation (c.465dupA) in exon 7. Given that residual p105 and p50—translated from the non-mutated alleles—were normal, and altered p50 proteins were absent, we conclude that the CVID phenotype in these families is caused by NF-κB1 p50 haploinsufficiency.

Indexed as

AustraliaBase SequenceBlotting, WesternCommon Variable ImmunodeficiencyDNA PrimersExomeHaploinsufficiencyHumansMicroscopy, FluorescenceMolecular Sequence DataNetherlandsNew ZealandNF-kappa B p50 SubunitSequence Analysis, DNADNA PrimersNF-kappa B p50 Subunit

Identifiers

PMID26279205
PMCPMC4564940
OpenAlexW1699352150

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.